Cargando…
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy
Due to the increasing threat to public health and the economy, governments internationally are interested in models to estimate the future clinical and economic burden of antimicrobial resistance (AMR) and to evaluate the cost-effectiveness of interventions to prevent or control resistance and to in...
Autores principales: | Hillock, Nadine T., Merlin, Tracy L., Turnidge, John, Karnon, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977126/ https://www.ncbi.nlm.nih.gov/pubmed/35368230 http://dx.doi.org/10.1007/s40258-022-00728-x |
Ejemplares similares
-
Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study
por: Hillock, Nadine T, et al.
Publicado: (2020) -
What will make a difference? Assessing the impact of policy and non-policy scenarios on estimations of the future GP workforce
por: Laurence, Caroline O. M., et al.
Publicado: (2017) -
It’s Not the Model, It’s the Way You Use It: Exploratory Early Health Economics Amid Complexity Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling"
por: Partington, Andrew, et al.
Publicado: (2020) -
Comparative analysis of Australian hospital antimicrobial utilization, using the WHO AWaRe classification system and the adapted Australian Priority Antimicrobial List (PAL)
por: Hillock, Nadine T, et al.
Publicado: (2021) -
Quantifying the Economic and Clinical Value of Reducing Antimicrobial Resistance in Gram-negative Pathogens Causing Hospital-Acquired Infections in Australia
por: Gordon, Jason P., et al.
Publicado: (2023)